Orthokeratology and 0.01% Atropine Sequential Treatment for Myopia Control
Status:
RECRUITING
Trial end date:
2027-03-31
Target enrollment:
Participant gender:
Summary
The purpose of this multicenter randomized clinical trial is to evaluate the myopia control effect of orthokeratology and 0.01% atropine sequential treatment in children and adolescents, as compared to continuous treatment with orthokeratology.
Phase:
NA
Details
Lead Sponsor:
Zhongshan Ophthalmic Center, Sun Yat-sen University
Collaborators:
Henan Provincial People's Hospital People's Hospital of Guangxi Tianjin Medical University Eye Hospital